This announcement is a separate document:
西点药业:海通证券关于西点药业2024半年度跟踪报告
West Point Pharmaceutical: Haitong Securities 2024 Semi-Annual Follow-up Report on West Point Pharmaceutical
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.